Difference between revisions of "Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 276: | Line 276: | ||
| | | | ||
|- | |- | ||
| − | | | + | |Myeloid Sarcoma||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Myeloid Proliferations Associated with Down Syndrome||'''''Overview'''''|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Myeloid Leukemia Associated with Down Syndrome||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Acute Leukemias of Ambiguous Lineage||'''''Overview'''''|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Acute Undifferentiated Leukemia||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | |??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH |
| | | | ||
| | | | ||
|- | |- | ||
| − | | | + | | || || || |
| | | | ||
| | | | ||
Revision as of 17:21, 21 May 2020
| Disease | Page Type | Author | Associate Editor | Author Content (Pending or Complete) | Editor Reviewed (Date) |
|---|---|---|---|---|---|
| Myeloproliferative Neoplasms (MPN) | Overview | Fabiola Quintero-Rivera (FQR) | |||
| Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive | Disease | FQR | |||
| Chronic Neutrophilic Leukemia (CNL) | Disease | FQR | |||
| Polycythaemia Vera (PV) | Disease | FQR | |||
| Primary Myelofibrosis (PMF) | Disease | FQR | |||
| Essential Thrombocythaemia (ET) | Disease | FQR | |||
| Chronic Eosinophilic Leukemia, Not Otherwise Specified | Disease | FQR | |||
| Myeloproliferative Neoplasm (MPN), Unclassifiable | Disease | FQR | |||
| Mastocytosis | Overview | FQR | |||
| Cutaneous Mastocytosis | Disease | FQR | |||
| Systemic Mastocytosis | Disease | FQR | |||
| Mast Cell Sarcoma | Disease | FQR | |||
| Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 | Overview | FQR | |||
| Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement | Disease | FQR | |||
| Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement | Disease | FQR | |||
| Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement | Disease | FQR | |||
| Myeloid/Lymphoid Neoplasms with PCM1-JAK2 | Disease | FQR | |||
| Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) | Overview | FQR | |||
| Chronic Myelomonocytic Leukemia (CMML) | Disease | FQR | |||
| Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative | Disease | FQR | |||
| Juvenile Myelomonocytic Leukemia (JMML) | Disease | FQR | |||
| Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) | Disease | FQR | |||
| Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable | Disease | FQR | |||
| Myelodysplastic Syndromes (MDS) | Overview | FQR | |||
| Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia | Disease | FQR | |||
| Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) | Disease | FQR | |||
| Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia | Disease | FQR | |||
| Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia | Disease | FQR | |||
| Myelodysplastic Syndrome (MDS) with Excess Blasts | Disease | FQR | |||
| Myelodysplastic Syndrome (MDS) with Isolated del(5q) | Disease | FQR | |||
| Myelodysplastic Syndrome (MDS), Unclassifiable | Disease | FQR | |||
| Refractory Cytopenia of Childhood | Disease | FQR | |||
| Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms | Overview | Jennelle Hodge (JH) | |||
| Myeloid Neoplasms with Germline Predisposition | Overview | JH | |||
| Acute Myeloid Leukaemia with Germline CEBPA Mutation | Disease | JH | |||
| Myeloid Neoplasms with Germline DDX41 Mutation | Disease | JH | |||
| Myeloid Neoplasms with Germline RUNX1 Mutation | Disease | JH | |||
| Myeloid Neoplasms with Germline ANKRD26 Mutation | Disease | JH | |||
| Myeloid Neoplasms with Germline ETV6 Mutation | Disease | JH | |||
| Myeloid Neoplasms with Germline GATA2 Mutation | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities | Overview | JH | |||
| Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | Disease | JH | |||
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Disease | JH | |||
| Acute Promyelocytic Leukemia (APL) with PML-RARA | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM | Disease | JH | |||
| Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with BCR-ABL1 | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with Mutated NPM1 | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with Mutated RUNX1 | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | Disease | JH | |||
| Therapy-Related Myeloid Neoplasms | Disease | JH | |||
| Acute Myeloid Leukemia (AML), Not Otherwise Specified | Overview | JH | |||
| Acute Myeloid Leukemia (AML) with Minimal Differentiation | Disease | JH | |||
| Acute Myeloid Leukemia (AML) without Maturation | Disease | JH | |||
| Acute Myeloid Leukemia (AML) with Maturation | Disease | JH | |||
| Acute Myelomonocytic Leukemia | Disease | JH | |||
| Acute Monoblastic and Monocytic Leukemia | Disease | JH | |||
| Pure Erythroid Leukemia | Disease | JH | |||
| Acute Megakaryoblastic Leukemia (AMKL) | Disease | JH | |||
| Acute Basophilic Leukemia | Disease | JH | |||
| Acute Panmyelosis with Myelofibrosis | Disease | JH | |||
| Myeloid Sarcoma | Disease | JH | |||
| Myeloid Proliferations Associated with Down Syndrome | Overview | JH | |||
| Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome | Disease | JH | |||
| Myeloid Leukemia Associated with Down Syndrome | Disease | JH | |||
| Blastic Plasmacytoid Dendritic Cell Neoplasm | Disease | JH | |||
| Acute Leukemias of Ambiguous Lineage | Overview | JH | |||
| Acute Undifferentiated Leukemia | Disease | JH | |||
| Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | Disease | JH | |||
| Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | Disease | JH | |||
| Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | Disease | JH | |||
| Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | Disease | JH | |||
| ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types | Disease | JH | |||
| ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS) | Disease | JH | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example | |||
| Example | Example | Example |